Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Data Sciences International (DSI) is the global leader in providing telemetry systems, respiratory solutions, associated software platforms, and scientific services to support life science researchers. Their technologies enable integrated physiologic monitoring of laboratory animals in preclinical studies across cardiovascular, neuroscience, safety pharmacology, toxicology, metabolism/glucose regulation, infectious disease models and more. DSI’s products are widely used by pharmaceutical companies, academic institutions, CROs/CMOs/CROs/CDMOs as well as government agencies to advance drug discovery and biomedical research. The company has a strong reputation built on nearly four decades of innovation in implantable/external telemetry devices and digital data acquisition/analysis platforms that comply with regulatory standards such as FDA GLP.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Data Sciences International.